Page Six may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. We found your new “Obsession.” One of the buzziest ...

Washington — President Trump's media company will sell faster access to Truth Social posts, where the president often announces policy updates and market-moving news. Trump Media & Technology Group ...

Summer is firmly here, and the temperatures are feeling borderline apocalyptic in much of the northern hemisphere. Why not avoid the angry sun and stay inside where it’s (hopefully) cooler and ...

Dr. Reddy’s Laboratories Ltd. cut the first-year manufacturing target for its generic Ozempic drug as it paused commercial production until at least October after finding an unknown impurity in a key ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Scientific model of the molecule semaglutide seen in Hellerup, Denmark, October 3, 2023. REUTERS/Ali Withers/File ...

When launching a drug as big as semaglutide, even as a generic, the market expectations are immense, and any fumble on the part of the drugmaker can take a toll. Case in point, Dr. Reddy’s share price ...

Reddy's says semaglutide API had an impurity issue, halts production of new batches Sees semaglutide supplies resuming in late October, early November Aims to sell 6-7 million semaglutide pens in ...

Dr. Reddy's Laboratories has announced a delay in the commercial supply of its semaglutide drug after identifying an issue with the active pharmaceutical ingredient (API) in certain batches. In this ...

A June inspection now has the FDA hitting Dr. Reddy’s with a Form 483, with seven observations spotted at its Indian biologics plant in Hyderabad during a site visit that wrapped up this week. The ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Amazon’s annual Prime Day sale might be best known for ...